Address

MedImmune Ventures Inc
One MedImmune Way
Gaithersburg, MD 20878
United States

Open map


Recent investment activity

KANDO id: 3030

Corporate information

Registration country

Funding rounds

Investment preferences


Investment activity status
Not investing

Selected investments

Displaying 1 - 25 of 30
Profile Country Date Sort descending Funding
Vanda Pharmaceuticals Inc Biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders. N/A
Inotek Pharmaceuticals Corp Inotek Pharmaceuticals is a clinical-stage ophthalmic pharmaceutical company. N/A
NeuProtect Pty Ltd N/A
NKT Therapeutics Inc N/A
Synovex Corp N/A
VLST Corp N/A
Xencor Inc Provider of protein engineering technology platforms in the biotechnology industry. N/A
Elusys Therapeutics Inc Develops antibody-based therapies to treat infectious diseases. N/A
Critical Therapeutics Inc Discoverer, developer and commercialize novel therapies. N/A
Tercica Inc A biopharmaceutical company developing new therapeutics for endocrine system disorders. N/A
VaxInnate Corp N/A
LigoCyte Pharmaceuticals Inc N/A
Sequoia Pharmaceuticals Inc Discovers and develops antiviral drugs that inhibits various forms of viruses and prevents the emergence of drug-resistant viruses. N/A
Applied Genetic Technologies Corp A gene therapy company that designs, packages and delivers therapeutic genes to treat a variety of medical illnesses using the adeno-associates virus. N/A
LigoCyte Pharmaceuticals Inc N/A
VentiRx Pharmaceuticals Inc N/A
Hydra Biosciences Inc N/A
Corridor Pharmaceuticals Inc N/A
Cellective Therapeutics Inc N/A
Iomai Corp Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. Series C
Avidia Inc Series B
VaxInnate Inc A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases. Series C
BrainCells Inc A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. Series B
Arginetix Inc Biopharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase. Seed
Virdante Pharmaceuticals Inc A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. Series A

Current team

Former team members

Employee Company Position
Edward Mathers New Enterprise Associates Inc
Partner
From

Responsibilities: Focus areas: Healthcare, Biopharma.

Selected Products / Customers

Financials